Patients with severe left ventricular dysfunction undergoing TAVI for aortic stenosis who experience an improvement in their ventricle’s function achieve mid-term mortality similar to that seen among ...

In patients with severe left ventricular systolic dysfunction on optimal medical therapy for HF, undergoing PCI did not improve rates of all-cause death or HF hospitalization, according to the results ...

Echocardiography can identify a range of cardiac abnormalities in COVID-19 patients who have biomarkers indicative of myocardial injury, a new study shows. Importantly, the combination of both ...

Vancouver, BC - The PET and Recovery Following Revascularization (PARR-2) trial showed that, among patients with severe left ventricular (LV) dysfunction, those who received fluorodeoxyglucose (FDG) ...

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease ...

Researchers in China report that a simple heart ultrasound measure of left ventricular underfilling is a valuable prognostic ...

Please provide your email address to receive an email when new articles are posted on . Key risk factors that may predict severe disease in patients with MIS-C include fever greater than 103.1 degrees ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...